Global Companion Diagnostics Market 2017-2025 - Rising Demand for Next-Generation Sequencing -

The Global Companion Diagnostics Market is poised to grow strong during the forecast period 2017 to 2025. Some of the prominent trends that the market is witnessing include growing prevalence of diseases, rising demand for next-generation sequencing, recent technological developments of companion diagnostics and growth opportunities/investment opportunities.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2014, 2015 revenue estimations are presented for 2016 and forecasts from 2017 till 2025.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

Report Highlights

  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2025, using estimated market values as the base numbers
  • Key market trends across the business segments, regions and countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2025
  • Market opportunities and recommendations for new investments

Key Topics Covered

1 Market Outline

2 Executive Summary

3 Market Overview

4 Companion Diagnostics Market, by Indication

5 Companion Diagnostics Market, by Product & Service

6 Companion Diagnostics Market, by Technology

7 Companion Diagnostics Market, by End User

8 Companion Diagnostics Market, by Geography

9 Key Player Activities

10 Leading Companies

  • Abnova Corporation
  • Novartis AG
  • Sysmex Corporation
  • Myriad Genetics Inc
  • Danaher Corporation
  • Abbott Laboratories Inc
  • Qiagen N.V.
  • F. Hoffmann-La Roche AG
  • Almac Group
  • Hologic Inc
  • Arup Laboratories Inc
  • Illumina Inc
  • Biomrieux SA
  • Thermo Fisher Scientific Inc
  • Agilent Technologies Inc

For more information about this report visit


Back to news